- ►endojournals.org J Gromada, I Franklin, CB Wollheim - Endocrine reviews, 2007 - Endocrine Soc Glucagon, a hormone secreted from the -cells of the endocrine pancreas, is critical for blood
glucose homeostasis. It is the major counterpart to insulin and is released during hypoglycemia
to induce hepatic glucose output. The control of glucagon secretion is multifactorial and ... Cited by 61 - Related articles - BL Direct - All 4 versions
P Fiorina, A Secchi - Endocrinology and Metabolism Clinics of North …, 2007 - Elsevier Islet cell transplantation recently has emerged as one the most promising therapeutic approaches
to improving glycometabolic control in type 1 diabetic patients, and, in many cases, to obtaining
insulin independence. Islet cell transplantation requires a relatively short hospital stay ... Cited by 13 - Related articles - All 17 versions
- ►ualberta.ca [PDF] RG Bretzel, H Jahr, M Eckhard, I Martin, D Winter, … - Langenbeck's Archives of …, 2007 - Springer Abstract Introduction Long-term studies strongly suggest that tight control of blood glucose can
prevent the development and retard the progression of chronic complications of type 1 diabetes
mellitus. In contrast to conventional insulin treat- ment, replacement of a patient's islets of ... Cited by 12 - Related articles - BL Direct - All 5 versions
- ►endojournals.org MR Rickels, MH Schutta, R Mueller, S Kapoor, … - Journal of Clinical …, 2007 - Endocrine Soc Context: In patients with type 1 diabetes and reduced awareness of hypoglycemia, the glycemic
thresholds for activation of counterregulatory hormone and symptom responses to hypoglycemia
are impaired, in part due to recurrent episodes of hypoglycemia. Islet transplantation can ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►endojournals.org X Huang, DJ Moore, RJ Ketchum, CS Nunemaker, B … - Endocrine …, 2008 - Endocrine Soc Although type 1 diabetes cannot be prevented or reversed, replacement of insulin production
by transplantation of the pancreas or pancreatic islets represents a definitive solution. At
present, transplantation can restore euglycemia, but this restoration is short-lived, ... Cited by 5 - Related articles - All 4 versions
JL Gaglia - Current Opinion in Endocrinology, Diabetes and …, 2006 - journals.lww.com Recent findings: Islet transplantation is considered a promising potential therapy for patients
with type 1 diabetes mellitus. It offers an attractive alternative to exogenous insulin with potentially
fewer complications and a larger supply of donor material than is available for solid organ ... Cited by 4 - Related articles - BL Direct - All 4 versions
MR Rickels, A Naji, KL Teff - Transplantation, 2007 - journals.lww.com Transplantation. Wolters Kluwer Health | Lippincott Williams & Wilkins. All Issues. ... Cited by 2 - Related articles - BL Direct - All 2 versions
- ►diabetesjournals.org H Zhou, T Zhang, M Bogdani, E Oseid, S Parazzoli, MC … - Diabetes, 2008 - Am Diabetes Assoc RESULTS— Glucagon (area under the curve) responses to hypoglycemia in the H group (8,839
± 1,988 pg/ml per 90 min) were significantly less than in normal rats (40,777 ± 8,192; P <
0.01). Fasting significantly decreased hepatic glycogen levels. Glucagon responses in the ... Cited by 3 - Related articles - All 4 versions
EA Ryan, AJ Shapiro - NATURE CLINICAL PRACTICE …, 2006 - phx1.medscape.com A 48-year-old woman who was diagnosed with type 1 diabetes 43 years previously, presented
early in 2001 to our Clinical Islet Transplant Program with recurrent hypoglycemia and glycemic
lability that had been present for several years. She was diligent with her diet, used a ... Cited by 1 - Related articles - BL Direct - All 8 versions
